Format

Send to

Choose Destination
J Thorac Oncol. 2017 Oct;12(10):e155-e157. doi: 10.1016/j.jtho.2017.04.023. Epub 2017 May 9.

Circulating Tumor DNA Identifies EGFR Coamplification as a Mechanism of Resistance to Crizotinib in a Patient with Advanced MET-Amplified Lung Adenocarcinoma.

Author information

1
Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
2
Foundation Medicine, Cambridge, Massachusetts.
3
Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
4
Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
5
Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: ashaw1@partners.org.
PMID:
28499860
PMCID:
PMC5610630
DOI:
10.1016/j.jtho.2017.04.023
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center